Latin America Pharma Growth: Boehringer Ingelhe...

By HEOR Staff Writer

January 27, 2026

Latin America Pharma Growth is surging as a high-growth engine for Boehringer Ingelheim, with double-digit market expansions outpacing mature regions like Europe, according to
NICE Endorses Talazoparib Enzalutamide for Prostate Cancer Treatment
Johnson & Johnson’s EMA Application for Teclistamab Daratumumab Th...
Accelerating Tec-Dara Multiple Myeloma Therapy Review: A Game Changer for Pat...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
Innovations in Haematology Cell Therapy at ASH 2025
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Promising Advances in TNBC Treatment: Sacituzumab Govitecan in First-Line The...